Bioglass®/chitosan-polycaprolactone bilayered composite scaffolds intended for osteochondral tissue engineering

Journal of Biomedical Materials Research - Part A

Volumn 102, Issue 12, 2014, Pages 4510-4518

  Yao, Qingqing ^a,b,c   Nooeaid, Patcharakamon ^b   Detsch, Rainer ^b   Roether, Judith A ^b   Dong, Yanming ^c   Goudouri, Ourania Menti ^b   Schubert, Dirk W ^b   Boccaccini, Aldo R ^b  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c XIAMEN UNIVERSITY   (China)

Author keywords

Bilayered scaffolds; Bioglass ; Chitosan; Osteochondral tissue engineering; Polycaprolactone

Indexed keywords

BIODEGRADATION; BIOMECHANICS; CHITIN; CHITOSAN; FOAMS; FOURIER TRANSFORM INFRARED SPECTROSCOPY; MECHANICAL PROPERTIES; PLASTIC COATINGS; POLYCAPROLACTONE; POLYMERS; SCANNING ELECTRON MICROSCOPY; TISSUE; TISSUE ENGINEERING; X RAY DIFFRACTION;

BILAYERED COMPOSITES; BILAYERED SCAFFOLDS; CELL VIABILITY; DRYING TECHNIQUE; OSTEOBLAST-LIKE CELLS; OSTEOCHONDRAL TISSUE ENGINEERING; POLYMER COATING; SIMULATED BODY FLUIDS;

SCAFFOLDS (BIOLOGY);

BIOCERAMICS; BIOGLASS; CHITOSAN; POLYCAPROLACTONE; POLYMER; UNCLASSIFIED DRUG; BIOACTIVE GLASS 45S5; BIOMATERIAL; CERAMICS; GLASS; POLYESTER;

ARTICLE; BILAYER MEMBRANE; BIODEGRADATION; BIOLOGICAL ACTIVITY; BODY FLUID; CARTILAGE; CELL ADHESION; CELL FUNCTION; CELL PROLIFERATION; CELL VIABILITY; COATED PARTICLE; COMPARATIVE STUDY; COMPRESSIVE STRENGTH; CONTROLLED STUDY; FREEZE DRYING; HUMAN; HUMAN CELL; IMMERSION; IN VITRO STUDY; INFRARED SPECTROSCOPY; OSTEOBLAST; OSTEOCHONDRAL TISSUE ENGINEERING; OSTEOSARCOMA CELL LINE; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; TISSUE ENGINEERING; TISSUE SCAFFOLD; X RAY DIFFRACTION; BONE; CELL SURVIVAL; CERAMICS; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; METABOLISM; PHARMACOLOGY; TUMOR CELL LINE;

BONE AND BONES; CARTILAGE; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CERAMICS; COATED MATERIALS, BIOCOMPATIBLE; GLASS; HUMANS; OSTEOBLASTS; POLYESTERS; TISSUE SCAFFOLDS;

EID: 84908632628     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.35125     Document Type: Article

References (51)

1. Malafaya PB, Reis RL. Bilayereded chitosan-based scaffolds for osteochondral tissue engineering: Influence of hydroxyapatite on in vitro cytotoxicity and dynamic bioactivity studies in a specific double-chamber bioreactor. Acta Biomater 2009;5:644-660.
2. Buckwalter JA. Articular cartilage: Injuries and potential for healing. J Orthop Sports Phys Ther 1998;28:192-202.
3. Redman SN, Oldfield SF, Archer CW. Current strategies for articular cartilage repair. Eur Cells Mater 2005;9:23-32.
4. Qi YY, Zhao TF, Xu K, Dai TY, Yan WQ. The restoration of fullthickness cartilage defects with mesenchymal stem cells (MSCs) loaded and cross-linked bilayered collagen scaffolds on rabbit model. Mol Biol Rep 2012;39:1231-1237.
5. Oliveira JM, Silva SS, Mano JF, Reis RL. Innovative technique for the preparation of porous bilayered hydroxyapatite/chitosan scaffolds for osteochondral applications. Key Eng Mater 2006;309-311:927-930.
6. Hung CT, Lima EG, Mauck RL, Takai E, LeRoux MA, Lu HH, Stark RG, Guo XE, Ateshian GA. Anatomically shaped osteochondral constructs for articular cartilage repair. J Biomech 2003;36:1853-1864.
7. Marcacci M, Kon E, Delcogliano M, Filardo G, Busacca M, Zaffagnini S. Arthroscopic autologous osteochondral grafting for cartilage defects of the knee: Prospective study results at a minimum 7-year follow-up. Am J Sports Med 2007;35:2014-2021.
8. Lee CY, Liu X, Hsu HC, Wang DY, Luo ZP. A modified cell culture method for autologous chondrocyte transplantation. Connect Tissue Res 2005;46:93-99.
9. Ait Si Selmi T, Neyret P, Verdonk PCM, Barnouin L. Autologous chondrocyte transplantation in combination with an alginate-agarose based hydrogel (Cartipatch). Tech Knee Surg 2007;6:253-258.
10. Swieszkowski W, Tuan BHS, Kurzydlowski KJ, Hutmacher DW. Repair and regeneration of osteochondral defects in the articular joints. Biomol Eng 2007;24:489-495.
11. Schek RM, Taboas JM, Segvich SJ, Hollister SJ, Krebsbach PH. Engineered osteochondral grafts using biphasic composite solid free-form fabricated scaffolds. Tissue Eng 2004;10:1376-1385.
12. Chen JN, Chen H, Li P, Diao HJ, Zhu SY, Dong L, Wang Rui, Guo T, Zhao JN, Zhang JF. Simultaneous regeneration of articular cartilage and subchondral bone in vivo using MSCs induced by a spatially controlled gene delivery system in bilayereded integrated scaffolds. Biomaterials 2011;32:4793-4805.
13. Temenoff JS, Mikos AG. Review: Tissue engineering for regeneration of articular cartilage. Biomaterials 2000;21:431-440.
14. Schaefer D, Martin I, Jundt G, Seidel J, Heberer M, Grodzinsky A, Bergin L, Vunjak-Novakovic G, Freed LE. Tissue engineered composites for the repair of large osteochondral defects. Arthritis Rheum 2002;46:2524-2534.
15. Schaefer D, Martin I, Shastri P, Padera RF, Langer R, Freed LE, Vunjak-Novakovic G. In vitro generation of osteochondral composites. Biomaterials 2000;21:2599-2606.
16. Pei M, Solchaga LA, Seidel J, Zeng L, Vunjak-Novakovic G, Caplan AI, Freed LE. Bioreactors mediate the effectiveness of tissue engineering scaffolds. FASEB J 2002;16:1691-1694.
17. Waldman SD, Spiteri CG, Grynpas MD, Pilliar RM, Hong J, Kandel RA. Effect of biomechanical conditioning on cartilaginous tissue formation in vitro. J Bone Joint Surg Am 2003;85A:101-105.
18. Shao XX, Hutmacher DW, Ho ST, Goh JCH, Lee EH. Evaluation of a hybrid scaffold/cell construct in repair of high-load-bearing osteochondral defects on rabbits. Biomaterials 2006;27:1071-1080.
19. Weng Y, Cao Y, Silva CA, Vacanti MP, Vacanti CA. Tissue-engineered composites of bone and cartilage for mandible condylar reconstruction. J Oral Maxillofac Surg 2001;59:185-190.
20. Isogai N, Landis W, Kim TH, Gerstedfeld LC, Uoton J, Wacanti JP. Formation of phalanges and small joints by tissue-engineering. J Bone Joint Surg Am 1999;81:306-316.
21. Oliveira JM, Rodrigues MT, Silva SS, Malafaya PB, Gomes ME, Viegas CA, Dias IR, Azevedo JT, Mano JF, Reis RL. Novel hydroxyapatite/chitosan bilayereded scaffold for osteochondral tissue-engineering applications: Scaffold design and its performance when seeded with goat bone marrow stromal cells. Biomaterials 2006;27:6123-6137.
22. Nooeaid P, Salih V, Beier JP, Boccaccini AR. Osteochondral tissue engineering: Scaffolds, stem cells and applications. J Cell Mol Med 2012;16:2247-2270.
23. Nooeaid P, Roether JA, Weber E, Schubert DW, Boccaccini AR. Technologies for multilayered scaffolds suitable for interface tissue engineering. Adv Eng Mater, in press.
24. Rahaman MN, Day DE, Bal BS, Fu Q, Jung SB, Bonewald LF, Tomsia AP. Bioactive glass in tissue engineering, Acta Biomater 2011;7:2355-2373.
25. Gerhardt LC, Boccaccini AR. Bioactive glass and glass-ceramic scaffolds for bone tissue engineering. Materials 2010;3:3867-3910.
26. Ducheyne P, Qiu Q. Bioactive ceramics: The effect of surface reactivity on bone formation and bone cell function. Biomaterials 1999;20:2287-2303.
27. Mohamad Yunos D, Bretcanu O, Boccaccini AR. Polymer-bioceramic composites for tissue engineering scaffolds. J Mater Sci 2008;43:4433-4442.
28. Yang G, Yang X, Zhang L, Lin M, Sun X, Chen X, Gou Z. Counterionic biopolymers-reinforced bioactive glass scaffolds with improved mechanical properties inwet state.Mater Lett 2012;75:80-83.
29. Chen QZ, Boccaccini AR. Poly (D, L-lactic acid) coated 45S5 BioglassVR-based scaffolds: Processing and characterization. J Biomed Mater Res A 2006;77A:445-457.
30. Di Martino A, Sittinger M, Risbud MV. Chitosan: A versatile biopolymer for orthopaedic tissue-engineering. Biomaterials 2005;26: 5983-5990.
31. Khor E, Lim LY. Implantable applications of chitin and chitosan. Biomaterials 2003;24:2339-2349.
32. Chen JD, Nan KH, Yin SH, Wang YJ, Wu T, Zhang QQ. Characterization and biocompatibility of nanohybrid scaffold prepared via in situ crystallization of hydroxyapatite in chitosan matrix. Colloid Surface B 2010;81:640-647.
33. Hao JY, Yuan ML, Deng XM. Biodegradable and biocompatible nanocomposites of poly(e-psilon-caprolactone) with hydroxyapatite nanocrystals: Thermal and mechanical properties. J Appl Polym Sci 2002;86:676-683.
34. Woodruff MA, Hutmacher DW. The return of a forgotten polymer: Polycaprolactone in the 21st century. Prog Polym Sci 2010;35: 1217-1256.
35. Sarasam A, Madihally SV. Characterization of chitosan-polycaprolactone blends for tissue engineering applications. Biomaterials 2005;26:5500-5508.
36. Chen QZ, Thompson ID, Boccaccini AR. 45S5 BioglassVR -derived glass-ceramic scaffolds for bone tissue engineering. Biomaterials 2006;27:2414-2425.
37. Yao QQ, Nooeaid P, Roether JA, Dong YM, Zhang QQ, Boccaccini AR. BioglassVR-based scaffolds incorporating polycaprolactone and chitosan coatings for controlled vancomycin delivery. Ceram Int 2013;39:7517-7522.
38. Kim HW, Knowles JC, Kim HE. Development of hydroxyapatite bone scaffold for controlled drug release via poly(epsilon-caprolactone) and hydroxyapatite hybrid coatings. J Biomed Mater Res B Appl Biomater 2004;70B:240-249.
39. Kokubo T, Hata K, Nakamura T, Yamamura T. Apatite formation on ceramics, metals, and polymers induced by a CaO-SiO2-based glass in simulated body fluid. In: Bonfield W, Hastings GW, Tanner KE, editors. Bioceramics, Vol. 4 London: Guildford, Butterworth- Heinemann; 1991. p 113-120.
40. Peroglio M, Gremillard L, Chevalier J, Chazeau L, Gauthier C, Hamaide T. Toughening of bio-ceramics scaffolds by polymer coating. J Eur Ceram Soc 2007;27:2679-2685.
41. Li JJ, Gil ES, Hayden RS, Li C, Roohani-Esfahani S-I, Kaplan DL, Zreiqat H. Multiple silk coatings on biphasic calcium phosphate scaffolds: Effect on physical and mechanical properties and in vitro osteogenic response of human mesenchymal stem cells. Biomacromolecules 2013;14:2179-2188.
42. Sarasam AR, Krishnaswamy RK, Madihally SV. Blending chitosan with polycaprolactone: Effects on physicochemical and antibacterial properties. Biomacromolecules 2006;7:1131-1138.
43. Chatzistavrou X, Zorba T, Kontonasaki E, Chrissafis K, Koidis P, Paraskevopoulos KM. Following bioactive glass behavior beyond melting temperature by thermal and optical methods. Phys Status Solid 2004;201:944-951.
44. Bretcanu O, Chatzistavrou X, Paraskevopoulos K, Conradt R, Thompson ID, Boccaccini AR. Sintering and crystallisation of 45S5 Bioglass VR powder. J Eur Ceram Soc 2009;29:3299-3306.
45. Elzein T, Nasser-Eddine M, Delaite C, Bistac S, Dumas P. FTIR study of polycaprolactone chain organization at interfaces. J Coll Interf Sci 2004;273:381-387.
46. Senda T, He Y, Inoue Y. Biodegradable blends of poly(e-caprolactone) wth a-chitin and chitosan: Specific interactions, thermal properties and crystallization behavior. Polym Int 2001;51:33-39.
47. George TS, Guru KSS, Vasanthi NS, Kannan KP. Extraction, purification and characterization of chitosan from endophytic fungi isolated from medicinal plants. World J Sci Technol 2011;1:43-48.
48. Madihally SV, Mattew HWT. Porous chitosan scaffolds for tissue engineering. Biomaterials 1999;20:1133-1142.
49. Kim HK, Jang JW, Lee CH. Surface modification of implant materials and its effect on attachment and proliferation of bone cells. J Mater Sci Mater Med 2004;15:825-830.
50. Chen QZ, Efthymiou A, Salih V, Boccaccini AR. BioglassVR - derived glass-ceramic scaffolds: Study of cell proliferation and scaffold degradation in vitro. J Biomed Mater Res A 2008;84: 1049-1060.
51. Liverani L, Roether JA, Nooeaid P, Trombetta M, Schubert DW, Boccaccini AR. Simple fabrication technique for multilayered stratified composite scaffolds suitable for interface tissue engineering. Mater Sci Eng 2012;A557:54-58.